Blood Glucose Test Strip Market is estimated to be valued at USD 13.28 Bn in 2026 and is expected to reach USD 22.17 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 13.28 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
7.60% |
2033 Value Projection: |
USD 22.17 Bn |
Blood glucose test strips are a central component of blood glucose measurement. These small, single-use plastic strips may look insignificant, but they play a very important role in helping people with diabetes monitor and control their diabetes.
Market Dynamics:
For instance, in September 2020, LifeScan IP Holdings, LLC, a diagnostic systems manufacturer has announced the launch of its OneTouch Amazon store for people with type 1 and type 2 diabetes. The new web store includes the launch of a OneTouch Verio 30-strip test strip value pack that, along with nine other one touch-branded products, gives consumers access to its flagship product at a lower price
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global blood glucose test strip market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, AgaMatrix, Bionime Corporation, ACON Laboratories, Inc., MEDISANA GMBH, Tividia Health, Inc., Rossmax International Ltd., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global blood glucose test strip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose test strip market.
Detailed Segmentation:
- Global Blood Glucose Test Strip Market, By Material Type (Revenue, USD Bn, 2021 - 2033)
- Thin Film Electrochemical Films
- Thick Film Electrochemical Films
- Optical strips
- Global Blood Glucose Test Strip Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Glucose Oxidase
- Glucose Dehydrogenase
- Global Blood Glucose Test Strip Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Type I Diabetes
- Type II Diabetes
- Global Blood Glucose Test Strip Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Home Care Settings
- Diagnostic Laboratories
- Others (Research and Academic Institutions, etc.)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Abbott
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- AgaMatrix
- Bionime Corporation
- ACON Laboratories, Inc.
- MEDISANA GMBH
- Tividia Health, Inc.
- Rossmax International Ltd.